Physician profile
Daniel Pagel
NPI 1174017834
$818.29
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.08 · 2020: $13.20 · 2021: $193 · 2022: $158 · 2023: $411 · 2024: $18.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $230 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $230.21 |
| Education | $200.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerr Corporation | $283.32 | 2021-2023 | Files |
| Straumann USA LLC | $271.28 | 2023 | |
| Dentsply Sirona INC | $81.99 | 2021 | |
| Nobel Biocare USA | $70.02 | 2023 | Nobelactive |
| Align Technology, INC. | $44.29 | 2020-2021 | |
| Biolase, INC. | $24.08 | 2019 | |
| Envista Holdings Corporation | $18.89 | 2024 | Harmonize |
| Gc America INC. | $12.47 | 2021 | |
| Orapharma, A Division of Bausch Health US, LLC | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Pagel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.